Fibronectin, a high molecular weight glycoprotein, is present in a soluble form in various body fluids as well as in an insoluble form at the surface of cells (Yamada and Olden 1978; Ruoslahti et al. 1981a ). Blood plasma (Mosesson and Umfleet 1970) , amniotic fluid (Chen et al. 1975; Crouch et al. 1978) , cerebrospinal fluid (Kuusela et al. 1978 ) and pleural fluid (Klockers et al. 1982 ) have been shown to contain a substantial amount of soluble fibronectin. Amniotic fluid fibronectin, which is assumed to be produced by epithelial cells of the amniotic membrane (Crouch et al. 1978 ; Alitalo et al. 1980) , differs from plasma fibronectin in content and composition of carbohydrate, although they are immunologically indistinguishable (Balian et al. 1979 ; Pande et al. 1981 ; Ruoslahti et al. 1981b ). Thus, it is likely that the difference in the carbohydrate moieties between the two forms of fibronectin will result in different lectin binding specificities (Pande et al. 1981) .
Crossed immunoaflinity electrophoresis with free lectins in the first dimension gel has been used to characterize the carbohydrate heterogeneity of glycoproteins such as a1-acid glycoprotein (Nicollet et al. 1981 ) and c -fetoprotein (Kerckaert et al. 1979) . By this method it is possible to compare quantitatively the degree of lectin affinity among fibronectins from various sources.
In this study, we compared the amino acid and carbohydrate compositions of fibronectins from adult plasma and amniotic fluid, and showed striking differences in Con A-reactivity between them by crossed immunoaffinity electrophoresis with free Con A and rocket immunoelectrophoresis with immobilized Con A intermediate gel. The results suggested structural differences in the carbohydrate moiety between the fibronectins, especially in the branching pattern of the carbohydrate chains.
MATERIALS AND METHODS
Isolation of fibronectin. Human fibronectin was purified from pooled adult plasma, fetal cord plasma, and amniotic fluid. Fetal plasma was obtained from the umbilical vessels of normal infants immediately after delivery. Amniotic fluid was collected from normal parturient women at term by means of an intrauterine catheter. To exclude the possibility of donor-to-donor variance, each of the body fluids was pooled for more than 20 individual donors. 7n addition to the pooled body fluids above, we used an ascitic fluid specimen from a patient with an ovarian cancer (serous cystoadenocarcinoma) as a source of fibronectin. These body fluid samples were pretreated with a plain Sepharose column and then fractionated on a column of gelatin coupled to Sepharose in 0.05 M Tris-HCl buffer, pH 7.5, containing 0.1 M NaCI, 20 mM E-aminocaproic acid and 1 mM EDTA ). The fibronectin preparations were dialyzed before use against 0.05 M Tris-HCL buffer, pH 7.5, containing 0.1 M NaCI. The fibronectin concentrations were determined by absorbance at 280 nm for adult plasma fibronectin (Mosesson and Umfleet 1970) and by conventional rocket immunoelectrophoresis for others using monospecific rabbit antiserum raised against plasma fibronectin ).
SDS-Polyacrylamide gel electrophoresis. Purification of fibronectin was monitored by SDS-gel electrophoresis using 5% polyacrylamide gels as described previously .
Chemical compositions. Amino acids, hexosamines, neutral sugars and sialic acid were determined as described previously ).
Immunological methods. Crossed immunoaffinity electrophoresis with free lectin in the first dimension gel was performed according to the method of Bog-Hansen et al. (1975) . The first dimension electrophoresis was carried out at 10 V/cm for 1 hr using 1% agarose gel in 0.06 M barbiturate buffer, pH 8.6, in the presence or absence of free Con A (Sigma Co.). The second dimension gel contained 30 , tl/ml of monospecific rabbit anti-human plasma fibronectin ) and electrophoresis was performed at 3 V/cm for 20 hr.
To compare the reactivities of plasma fibronectin and amniotic fluid fibronectin to immobilized Con A, rocket immunoelectrophoresis with Con A-Sepharose intermediate gel was also carried out. In this method a known amount of fibronectin was electrophoresed across the various widths of the Con A-Sepharose intermediate gel. The amount trapped in the intermediate gel was quantitated by means of rocket immunoelectrophoresis of standard samples on the same plate. The degree of reactivity is expressed by the width of the intermediate gel required to trap half of the applied amount. The Con A content in the Con A-Sepharose was 9.3 mg/ml. Electrophoresis was performed at 2 V/cm for 12 hr.
RESULTS

SDS-Polyacrylamide gel electrophoresis of plasma and amniotic fluid fibronectins
SDS-Polyacrylamide gel electrophoresis demonstrated the purity of these fibronectins (Fig. 1 ).
Chemical composition of plasma and amniotic fluid fibronectins
The amino acid compositions of plasma and amniotic fluid fibronectins are shown in Table 1 . There seemed to be no substantial differences between these amino acid compositions. On the other hand, substantial differences were observed between the two fibronectins in the carbohydrate composition ( Table 2) . Amniotic fluid fibronectin contained considerable amounts of fucose and galactosamine which were not found in plasma fibronectin. Galactose and glucosamine were present in amniotic fluid fibronectin in quantities about 4 and 2 times larger, respectively, than those in plasma fibronectin, whereas the amounts of mannose and sialic acid were essentially the same in both.
Crossed immunoafnity electrophoresis
Crossed immunoaffinity electrophoresis with free Con A was performed in order to study the possible differences in carbohydrate structure among fibronectins from various sources (Fig. 2) . A marked contrast was observed between the Con A-reactivity of adult plasma fibronectin and that of amniotic fluid fibronectin. With Con A at the level of 1 mg/ml in the first dimension gel, the precipitin line of plasma fibronectin shifted to the catholic direction and its peak height became markedly lower, whereas that of amniotic fluid fibronectin appeared to be unaffected (Figs. 2-I and 2-II) . As the cathodic shift and the reduction in the area of precipitates are elicited by the formation of lectin-glycoprotein complexes be weaker than that of adult plasma fibronectin (Figs. 2-III and 2-IV). The migration distance in the lectin -containing first dimension gels and the areas of precipitates relative to those in control gels were calculated for quantitative comparison (Table 3) . These values suggest that the fibronectin from cancer ascitic fluid has a Con A-reactivity intermediate between that of adult plasma fibronectin and that of amniotic fluid fibronectin, and that fetal plasma fibronectin has a slightly weaker Con A-reactivity than does adult plasma fibronectin. Each fibronectin preparation gave a single precipitin peak (Fig. 2) . The multiple-peak pattern as reported for al-acid glycoprotein (Nicollet et al. 1981 ) and c -fetoprotein (Kerckaert et al. 1979) was not observed even when experiments were performed at various concentrations of Con A between 0.1 mg/ml and 5 mg/ml. 
Rocket immunoelectrophoresis with Con A-Sepharose intermediate gel
The result showed the striking difference in the reactivity of adult plasma fibronectin and amniotic fluid fibronectin to immobilized Con A (Fig. 3) . The widths of intermediate gels required to halve the applied amount were 2.1 mm and 18.5 mm for adult plasma and amniotic fluid fibronectin, respectively.
DISCUSSION
It has recently been demonstrated that fibronectins from various sources substantially differ in their carbohydrate compositions.
Fibronectins from human amniotic fluid (Balian et al. 1979; Pande et al. 1981; Ruoslahti et al. 1981b ) and virally transformed hamster cells (Wagner et al. 1981) are examples of fibronectins which have larger amounts of carbohydrate per molecule than that from human plasma. The results of carbohydrate analyses in this study indicate that fibronectin from adult plasma and that from amniotic fluid at term have carbohydrates which are about 4% and 8% of total weight, respectively. The present findings for carbohydrate composition of term amniotic fluid are essentially the same as those reported by Ruoslahti et al. (1981b) , although the total carbohydrate contents are somewhat different. The higher contents of galactose and glucosamine in amniotic fluid fibronectin suggest that the sugar chains of this glycoprotein have more branches per core than those of plasma fibronectin.
Crossed immunoaffinity electrophoresis with free Con A (Fig. 2) as well as rocket immunoelectrophoresis with Con A-Sepharose intermediate gel (Fig. 3 ) revealed a striking difference between adult plasma fibronectin and amniotic fluid fibronectin with respect to the reactivity with this lectin. Con A is known to bind biantennary complex-type oligosaccharides but not tri-and tetraantennary structures (Baenziger and Fiete 1979) . Adult plasma fibronectin showed the strongest interaction of the four different fibronectins studied. This result is consistent with previous reports (Wrann 1978; Takahashi et al. 1980 ) that demonstrated 4 to 6 biantennary, asparagine-linked oligosaccharide chains per plasma fibronectin subunit. On the contrary, crossed immunoaffinity electrophoresis of amniotic fluid fibronectin demonstrated little or no interaction with Con A as evidenced by no change in mobility and no reduction in the area of precipitate. This result, together with its carbohydrate composition, suggests that a majority of sugar chains of amniotic fluid fibronectin may have tri-or tetraantennary structures. Furthermore, since the multiple-peak pattern of the precipitin lines which indicates the presence of distinct subpopulations (Kerckaert et al. 1979; Nicollet et al. 1981) was not observed, amniotic fluid fibronectin was considered to be composed of a rather homogeneous population with respect to the carbohydrate chains. Thus, amniotic fluid fibronectin is assumed to have multiple glycosylation sites almost all of which are attached by tri-or tetraantennary oligosaccharide chains.
Fibronectin isolated from pooled fetal plasma behaved differently from adult plasma fibronectin in the presence of Con A (Fig. 2, Table 3 ). This difference in Con A-reactivity, although it was not a marked difference, was constantly found in repeated runs of crossed immunoaffinity electrophoresis. In addition, a weaker Con A-reactivity of fetal plasma fibronectin than that of adult plasma fibronectin has also been demonstrated by crossed immunoaffinity electrophoresis with immobilized Con A intermediate gel (unpublished result). To elucidate the possible difference between fetal and adult plasma fibronectins, we are presently undertaking a further study on the glycopeptides of these fibronectins. We found a substantial amount of fibronectin (190 pg/ml by rocket immunoelectrophoresis) in ascitic fluid from a patient with an ovarian cancer. Although the carbohydrate analysis has not been performed because of limited volume of sample available, the fact that this fibronectin behaved differently from plasma fibronectin in crossed immunoafnity electrophoresis (Fig. 2 . Table 3 ) suggests that they are differently glycosylated. It will be of clinical interest to know whether the appearance of such fibronectin is constantly related to some specific types of malignant tumors or not.
There have been several reports which showed that the same (or very similar)
glycoproteins from different sources are glycosylated differently. For instance, a-fetoprotein in the second trimester amniotic fluid which is presumed to be of a yolk sac origin contains a large proportion of Con A-nonreactive variant whereas circulating a-fetoprotein which originates from the liver is mostly composed of Con A-reactive variant (Ruoslahti and Adamson 1978; ). The present results on plasma and amniotic fluid fibronectins have some analogy with the case of a-fetoprotein, that is, these glycoproteins in amniotic fluid have more Con A-nonreactive characteristics than those in plasma. However, why fibronectin in amniotic fluid carries a larger amount of carbohydrate is so far unknown. It should offer important information for the understanding of the environment of the fetus to know the specific biological role(s) of the carbohydrate moiety of amniotic fluid fibronectin.
